Story

Kenvue Stock Declines After Q2 Earnings and Revenue Miss

ENTHMSVIIDZHZH-TWJAKOHI
Aug 6, 20261 min read
Kenvue Stock Declines After Q2 Earnings and Revenue Miss
Text size
Background

Kenvue (KVUE) shares declined in pre-market trading after the consumer health products company reported second-quarter 2026 financial results that fell short of Wall Street expectations on both revenue and profit.

Q2 Results Fall Short

Kenvue announced adjusted earnings per share and revenue that narrowly missed consensus forecasts, overshadowing underlying growth in its business.

  • Adjusted EPS: $0.31, compared to the analyst consensus of $0.32.
  • Revenue: $3.96 billion, just below the expected $3.97 billion.

The company noted that net sales grew 3.0% year-over-year, while organic sales increased 1.6%. According to the release, this marked the third consecutive quarter of growth across all of Kenvue's segments and regions, though the headline miss drew the focus of investors.

Acquisition Creates Uncertainty

Sample IUX Markets – In-articleAd

Compounding the pressure on the stock, Kenvue did not host its customary quarterly earnings call with analysts and investors. The company cited its pending $48.7 billion acquisition by Kimberly-Clark, which is now anticipated to close in the fourth quarter of the year.

The absence of a call and management commentary left investors without context for the earnings shortfall or an update on the integration timeline. Kenvue also continued its practice of withholding full-year financial guidance since the deal was announced, limiting forward visibility for the market.

Broader Market Context

The stock's decline occurred against a mixed market backdrop, offering little support for consumer staples names. Adding to sector-specific concerns, Kimberly-Clark's recent earnings report included cautious commentary on weakening sentiment among lower-income consumers, a potential headwind for Kenvue's product portfolio as well. In pre-open trading, Kenvue stock slipped 1.8% to $19.31.

Read next

More on Stocks
Back to latest news

LATEST